MAPT and Cognitive impairment: Along with pathogenic mutations, genetic variants in at least 3 genes, apolipoprotein E (APOE), microtubule-associated protein tau (MAPT), and α-synuclein (SNCA), might play a role in determining susceptibility to cognitive impairment in PD [10].